Search Results

The company is positioned to supply over 55 million doses of influenza vaccines to healthcare providers across the U.S.

https://www.cslseqirus.us/news/csl-seqirus-begins-shipping-portfolio-of-innovative-influenza-vaccines-for-2023-24-us-season

Results from a retrospective cohort study from 2015 to 2020 demonstrated a notable rise with increasing age in pneumonia-related medical encounters following an influenza encounter.

https://www.cslseqirus.us/news/csl-seqirus-presents-rwe-at-eswi-demonstrating-impact-of-influenza-vaccination-campaigns

CSL Seqirus is a world leader in developing and producing influenza vaccines. Learn more about how we work with our partners to protect the global community.

https://www.cslseqirus.us/products

Influenza is a common, highly contagious infection that can lead to life-threatening complications. Learn more about influenza and our cutting-edge vaccines.

https://www.cslseqirus.us/expertise/influenza

CSL Seqirus will deliver further H5N8 A/Astrakhan antigen to support the U.S. government's pandemic preparedness activities

https://www.cslseqirus.us/news/csl-seqirus-announces-third-us-government-award-in-relation-to-influenza-a-h5n8-candidate-vaccine

CSL Seqirus brings multifaceted expertise to influenza prevention, employing both egg and cell-based technologies to meet the global community's needs.

https://www.cslseqirus.us/expertise

Read the latest news from Seqirus, a world leader in developing and producing influenza vaccines.

https://www.cslseqirus.us/news

Data published in Molecular Therapy – Methods and Clinical Development confirm the potential preclinical benefit of the sa-mRNA technology platform, the next generation of mRNA vaccine technology

https://www.cslseqirus.us/news/csl-announces-positive-preclinical-data-for-self-amplifying-messenger-rna-flu-vaccine-candidates

CSL Seqirus has been on the front line of pandemic preparedness for more than a century. Learn more about our rapid vaccine production capabilities.

https://www.cslseqirus.us/expertise/influenza/pandemic-response-solutions

CSL Seqirus stands with our partners on the front line of public health. We are the largest fully integrated commercialisation partner in Australia and New Zealand. Learn more.

https://www.cslseqirus.us/partnering